Skip to content

LearningRx Cognitive Training for Brain Injury

LearningRx Cognitive Training for Traumatic Brain Injury (TBI) and Acquired Brain Injury (ABI)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02918994
Enrollment
30
Registered
2016-09-29
Start date
2016-09-01
Completion date
2027-12-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury, Post COVID-19 Cognitive Impairment, Traumatic Brain Injury (TBI)

Brief summary

The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, daily functioning, and workplace self-efficacy for participants with Traumatic Brain Injury (TBI) /Acquired Brain Injury (ABI).

Detailed description

The proposed study will examine the outcomes from LearningRx one-on-one cognitive training across domains on standardized measures and qualitative measures used to monitor treatment effectiveness for brain injury.

Interventions

A clinician will deliver three 90-minute cognitive training sessions per week for 14 weeks. There are 16 different categories of leveled training procedures sequenced in intensity and difficulty for a total of 530 training tasks. Participants will receive training in-person or remotely depending on state of residence.

Sponsors

Gibson Institute of Cognitive Research
Lead SponsorINDUSTRY
Louisiana State University Health Sciences Center Shreveport
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

\- Age 18+ previously diagnosed with TBI/ABI

Exclusion criteria

* No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging for participants receiving MRI only

Design outcomes

Primary

MeasureTime frameDescription
Evidence of Change in Workplace Self-EfficacyBaseline and 9 monthsConfirmed by change on 29-item Workplace Self-Efficacy Survey

Secondary

MeasureTime frameDescription
Evidence of overall cognitive function improvementBaseline and 9 monthsConfirmed by change in pretest to post-test scores on the Woodcock Johnson IV - Tests of Cognitive Abilities
Evidence of Change in Self-Reported Functioning at Home and WorkBaseline and 9 monthsConfirmed by qualitative interview of pre-intervention symptoms and functioning and post-intervention symptoms and functioning
Evidence of reduction in TBI symptomsBaseline and 9 monthsAs confirmed by pretest to post-test changes on the Traumatic Brain Injury Checklist (Note: for TBI participants only)
Evidence of change in brain activityBaseline and 9 monthsAs confirmed by pretest to post-test changes in electrical activity measured by qEEG. (Note: for TBI in-person participants only; not for remote participants)
Evidence of change in brain structureBaseline and 9 monthsConfirmed by change in pretest to post-test neuroimaging using MRI. (Note: for in-person TBI participants only; not for remote participants.)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChristina Ledbetter, PhD

Gibson Institute of Cognitive Research and LSU Health Shreveport

STUDY_DIRECTORAmy L Moore, PhD

Gibson Institute of Cognitive Research

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026